HealthEquity Shares Outstanding 2014-2025 | HQY
HealthEquity shares outstanding history from 2014 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- HealthEquity shares outstanding for the quarter ending April 30, 2025 were 0.088B, a 0.1% increase year-over-year.
- HealthEquity 2025 shares outstanding were 0.089B, a 2.15% increase from 2024.
- HealthEquity 2024 shares outstanding were 0.087B, a 2.98% increase from 2023.
- HealthEquity 2023 shares outstanding were 0.084B, a 1.57% increase from 2022.
| HealthEquity Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 89 |
| 2024 | 87 |
| 2023 | 84 |
| 2022 | 83 |
| 2021 | 76 |
| 2020 | 68 |
| 2019 | 63 |
| 2018 | 62 |
| 2017 | 60 |
| 2016 | 59 |
| 2015 | 52 |
| 2014 | 6 |
| 2013 | 38 |
| HealthEquity Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-04-30 | 88 |
| 2025-01-31 | 89 |
| 2024-10-31 | 89 |
| 2024-07-31 | 89 |
| 2024-04-30 | 88 |
| 2024-01-31 | 87 |
| 2023-10-31 | 87 |
| 2023-07-31 | 86 |
| 2023-04-30 | 86 |
| 2023-01-31 | 84 |
| 2022-10-31 | 85 |
| 2022-07-31 | 84 |
| 2022-04-30 | 84 |
| 2022-01-31 | 83 |
| 2021-10-31 | 84 |
| 2021-07-31 | 83 |
| 2021-04-30 | 82 |
| 2021-01-31 | 76 |
| 2020-10-31 | 78 |
| 2020-07-31 | 72 |
| 2020-04-30 | 72 |
| 2020-01-31 | 68 |
| 2019-10-31 | 71 |
| 2019-07-31 | 66 |
| 2019-04-30 | 64 |
| 2019-01-31 | 63 |
| 2018-10-31 | 64 |
| 2018-07-31 | 63 |
| 2018-04-30 | 63 |
| 2018-01-31 | 62 |
| 2017-10-31 | 62 |
| 2017-07-31 | 62 |
| 2017-04-30 | 61 |
| 2017-01-31 | 60 |
| 2016-10-31 | 60 |
| 2016-07-31 | 60 |
| 2016-04-30 | 59 |
| 2016-01-31 | 59 |
| 2015-10-31 | 59 |
| 2015-07-31 | 59 |
| 2015-04-30 | 58 |
| 2015-01-31 | 52 |
| 2014-10-31 | 58 |
| 2014-07-31 | 42 |
| 2014-04-30 | 44 |
| 2014-01-31 | |
| 2013-10-31 | 29 |
| 2013-07-31 | 38 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.068B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.179B | 27.04 |
| CVS Health (CVS) | United States | $86.198B | 10.71 |
| Elevance Health (ELV) | United States | $84.314B | 10.88 |
| Cencora (COR) | United States | $57.484B | 20.00 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.963B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.509B | 17.45 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.205B | 0.00 |
| Solventum (SOLV) | United States | $12.912B | 13.67 |
| CochLear (CHEOY) | Australia | $12.870B | 0.00 |
| ICON (ICLR) | Ireland | $11.851B | 11.02 |
| Revvity (RVTY) | United States | $11.644B | 20.04 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Avantor (AVTR) | United States | $9.363B | 13.60 |
| Medpace Holdings (MEDP) | United States | $8.818B | 23.42 |
| Sonic Healthcare (SKHHY) | Australia | $8.465B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.445B | 14.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.269B | 25.15 |
| BrightSpring Health Services (BTSG) | United States | $4.058B | 37.23 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.781B | 36.17 |
| Alignment Healthcare (ALHC) | United States | $2.722B | 0.00 |
| Concentras Parent (CON) | United States | $2.652B | 15.33 |
| Organon (OGN) | United States | $2.594B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.556B | 98.45 |
| PACS (PACS) | United States | $1.958B | 0.00 |
| Ardent Health (ARDT) | United States | $1.904B | 8.12 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.796B | 13.63 |
| GoodRx Holdings (GDRX) | United States | $1.761B | 35.21 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.181B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| CareDx (CDNA) | United States | $1.074B | 16.77 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| LifeMD (LFMD) | United States | $0.615B | 0.00 |
| Embecta (EMBC) | United States | $0.542B | 3.65 |
| InnovAge Holding (INNV) | United States | $0.532B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| SBC Medicals (SBC) | United States | $0.464B | 0.00 |
| Omada Health (OMDA) | $0.460B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.312B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.249B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| So-Young (SY) | China | $0.209B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.096B | 0.00 |
| KindlyMD (NAKA) | United States | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.051B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |